PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 25, 2019SHILAP Revista de lepidopterología59 citationsOpen Access

Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy

View Full Paper
LALachlan M. AngusSLShalem LeemaqzOOOlivia Ooi

Key Points

Key points are not available for this paper at this time.

Abstract

The cyproterone group achieved serum total testosterone concentrations in the female reference range. As spironolactone may cause feminisation without inhibition of steroidogenesis, it is unclear which anti-androgen is more effective at feminisation. Further prospective studies are required.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Angus et al. (2019) studied this question.

synapsesocial.com/papers/69d742038e958094d1b8a93bhttps://doi.org/10.1530/ec-19-0272
Ask AI
Helpful
Bookmark
Share
View Full Paper